News
News & Events

 For IMMEDIATE RELEASE   


Dechra Acquires Exclusive License from Hassinger Biomedical for Equine ProVet APC™


Dechra Veterinary Products is pleased to announce the acquisition of the veterinary marketing and distribution rights to the ProVet APC™ (Autologous Platelet Concentrate) and ProVet BMC™ (Bone Marrow Concentrate) systems from Hassinger Biomedical. These two patented medical devices concentrate platelets or bone marrow in 90 seconds with a processing time of 2.5 minutes from start to finish. 

The ProVet APC system is a revolutionary device and is arguably the fastest and most transportable platelet concentrator available to the veterinary industry at less than 3 pounds total weight. Some of the system features include the ability to isolate approximately 90% of available platelets and growth factors, delivering the highest level of reproducibility with a low 3.5% coefficient of variance and a 97% reduction in red blood cell numbers.

The proprietary technology found within ProVet APC consistently delivers 6 to 8mls of 7.8 times high concentration of platelet rich plasma and a healing concentrate derived from 54mls of whole blood in the 60ml system.

Mike Eldred, President of Dechra North America stated, “The medical industry has long recognized that harnessing the growth factors found in platelets positively enhances healing results and reduces recovery time in soft tissue injuries.  These two products will be great additions to our equine product line and further strengthen our market position in veterinary regenerative medicine”.

“ProVet APC has become the most highly sought-after regenerative system for equine athletes”, said Amy Hassinger, CEO Hassinger Biomedical.  “We believe Dechra is specially poised, through their experience in the veterinary sector to meet the growing global demand by veterinarians and their clients for the ProVet APC and BMC Regenerative Therapy Systems. “

This addition of the Provet APC products to Dechra’s equine portfolio will complement our industry leading Orthokine® Vet irap joint therapy and provides veterinarians with a one stop partner for their regenerative medicine needs.

About Dechra

Dechra Veterinary Products, located in Overland Park, Kansas, is the U.S. sales and marketing division of Dechra Pharmaceuticals PLC, a UK listed company dedicated to the animal healthcare market. Dechra’s equine product line includes Osphos® (clodronate injection), Orthokine® vet irap 10 and 60, Osteokine® (PRP), Equidone® (domperidone) Gel, the Vetivex® line of parenteral fluids, Phycox® EQ, and a comprehensive line of topical dermatologic products. The recent addition of Zimeta® (dipyrone injection) further expands Dechra’s equine offerings. Dechra Veterinary Products’ companion animal portfolio focuses on endocrinology, dermatology, ophthalmology, anesthesia, fluid therapy, pain management, joint health support, and dental care. Our companion animal brands include Vetoryl® Capsules (trilostane), Zycortal® Suspension (desoxycorticosterone pivalate injectable suspension), Osurnia® (florfenicol-terbinafine-betamethasone acetate), Mirataz® (mirtazapine transdermal ointment), and Phycox® joint health supplements, Porus® One as well as a comprehensive topical dermatologic line for veterinary use. For more information, please visit www.dechra-us.com or call (866) 933-2472.


Treating Equine Lameness with 
the ProVet PRP system Case report

Phillip D. Hammock, DVM, MS, MRCVS, Diplomate ACVS

Ace 17 year old AQH Gelding Used for roping
Injury- RF DDF tendonopathy with annular ligament desmitis and scar tissue within the digital sheath. Injury first occurred in 2017- has been managed with PRP and then surgery in 2019. The area was re-injured in November 2020.
Presentation- Ace was 3/5 lame RF at a walk and 4/5 when trying to trot. The digital sheath was effusive and warm to touch. Moderate effusion was present in the fetlock joint as well. He would not tolerate flexion of the fetlock.
Treatment- Ace was treated with PRP utilizing the ProVet system. 8ml of PRP was obtained. 5ml was injected into the digital sheath and 3ml was injected into the fetlock joint. The fetlock was bandaged and the horse left turned out on pasture. The bandage was removed in 48 hours.
Response- In 72 hours, the lameness had improved to 2/5 (walking sound but head bobbing lame at trot). Slight decrease in effusion of the fetlock and 50% decrease in swelling of the digital sheath. On day 7 post-injection, the lameness had improved to sound at walk and 1/5 at trot (intermittent lameness). As he was turned out with other horses, he was observed to gallop periodically and began "playing" with the others.
Conclusion- In my opinion, this is a pretty remarkable response. Having had the opportunity to be the treating veterinarian for several years, dealing with the same issue, and seeing responses to different treatments, gives me comfort that this product does what it claims to do. The process is quick and easy and the results are excellent.

 “World’s Largest fleet of Equine Mobile Hospitals uses ProVet APC for Regenerative Healing”

Hassinger Equine Sports Medicine and Rehabilitation, based in Aberdeen, NC manages multiple self-contained mobile equine hospitals that travel to top competitions in the United States. Hassinger Equine’ staff of equine sports medicine veterinarians utilize the The ProVet Platelet Concentration System to treat a variety of bone and soft tissue injuries. 

The ProVet Platelet Concentration System is my first choice for joint/regenerative therapy in horses! The portable design allows you to process the highest quality biologic treatment right at the patient’s side. 
The system is cost effective, rapid and provides a higher volume of product for therapeutic treatment of multiple joints in horses. The rapid 
anti-inflammatory response is the best I have seen.”

Dr. James Hassinger
Hassinger Equine Sports Medicine & Rehabilitation
“World’s Largest fleet of Equine Mobile Hospitals uses ProVet APC for Regenerative Healing”

Hassinger Equine Sports Medicine and Rehabilitation, based in Aberdeen, NC manages multiple self-contained mobile equine hospitals that travel to top competitions in the United States. Hassinger Equine’ staff of equine sports medicine veterinarians utilize the Platelet Concentration System to treat a variety of bone and soft tissue injuries. 

"The ProVet Platelet Concentration System is my first choice for joint/regenerative therapy in horses! The portable design allows you to process the highest quality biologic treatment right at the patient’s side. The system is cost effective, rapid and provides a higher volume of product for therapeutic treatment of multiple joints in horses. The rapid anti-inflammatory response is the best I have seen.”

Dr. James Hassinger
Hassinger Equine Sports Medicine 
& Rehabilitation
Learn More
Share by: